On November 10, 2020, Discovery Life Sciences‘ Dr. Shawn Levy—Chief Scientific Officer of Discovery Life Sciences’ sequencing and bioinformatics laboratory, HudsonAlpha Discovery—presented about some of their latest technologies. He explained how Discovery Life Sciences has developed a new bundled solution leveraging Illumina’s TruSight Oncology 500 (TSO00) Solid Tumor (FFPE) and cfDNA that delivers actionable, reliable NGS data across matched FFPE tumor and plasma biospecimens and discussed how their services could be used to advance biomarker programs. You can access the entire presentation recording below, including a very informative Q&A session.
> If you are interested in hosting a webinar with Scientist.com, please contact us at email@example.com
Founded in 2007, Scientist.com is the world’s leading scientific services marketplace. It saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies. Scientist.com operates private marketplaces for most of the world’s major pharmaceutical companies and the US NIH.